Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 737-743

  Sung, Kyung Rim ^a   Cho, Jung Woo ^a   Lee, Suhwan ^a   Yun, Sung Cheol ^b   Choi, Jaewan ^c   Na, Jung Hwa ^a   Lee, Youngrok ^a   Kook, Michael Scott ^a  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Hangil Eye Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DORZOLAMIDE PLUS TIMOLOL; PROSTAGLANDIN DERIVATIVE; TIMOLOL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OCULAR PERFUSION PRESSURE; PERFUSION PRESSURE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RISK FACTOR; VISUAL FIELD DEFECT; VISUAL SYSTEM EXAMINATION; BLOOD PRESSURE; DRUG COMBINATION; FOLLOW UP; GONIOSCOPY; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; VISUAL DISORDER; VISUAL FIELD;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE PROGRESSION; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GONIOSCOPY; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TONOMETRY, OCULAR; VISION DISORDERS; VISUAL FIELDS;

EID: 79953272507     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5351     Document Type: Article

References (26)

1. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126:498-505.
2. Choi J, Jeong J, Cho HS, et al. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Oph-thalmol Vis Sci. 2006;47:831-836.
3. Choi J, Kim KH, Jeong J, et al. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophthalmol Vis Sci. 2007;48:104-111.
4. Sung KR, Lee S, Park SB, et al. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci. 2009;50:5266-5274.
5. Caprioli J, Spaeth GL. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am J Ophthalmol. 1984;97:730-737.
6. Koseki N, Araie M, Suzuki Y et al. Visual field damage proximal to fixation in normal- and high-tension glaucoma eyes. Jpn J Ophthal-mol. 1995;39:274-283.
7. Araie M, Yamagami J, Suziki Y. Visual field defects in normal-tension and high-tension glaucoma. Ophthalmology. 1993;100: 1808-1814.
8. Ahrlich K, De Moraes CG, Teng CC, et al. Visual field progression differences between normal-tension and exfoliative high-tension glaucoma patients. Invest Ophthalmol Vis Sci. 2010;51: 1458- 1463.
9. Anderson DR. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol. 2004;43:S5-S9.
10. Sherwood L. Human Physiology: From Cells to Systems. 5th ed. Pacific Grove, CA: Brooks Cole; 2004.
11. Gherghel D, Orgul S, Gugleta K, et al. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am J Ophthalmol. 2000;130: 597-605.
12. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it: myth and reality. Prog Retin Eye Res. 2001;20: 563-593.
13. Bisantis C. Ocular blood flow and its autoregulation. In: Bucci MG eds. Glaucoma: Decision Making in Therapy. Milan, Italy: Springer-Verlag; 1996;37-40.
14. Collignon N, Dewe W, Guillaume S, et al. Ambulatory blood pressure monitoring in glaucoma patients: the nocturnal systolic dip and its relationship with disease progression. Int Ophthalmol. 1998;22:19-25.
15. Watanabe N, Imai Y, Nagai K, et al. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke. 1996;27: 1319-1327.
16. Anderson DR. Automated Static Perimetry 1992. St. Louis: C.V. Mosby. 1992;91-137.
17. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmo-logica. 1999;213:76-96.
18. Topouzis F, Coleman AL, Harris A, et al. Association of blood pressure stauts with the optic disk structure in non-glaucoma subjects: The Thessaloniki Eye Study. Am J Ophthalmol. 2006;142: 60-67.
19. Muskens RPH, de Voogd S, Wolfs RCW, et al. Systemic antihyper- tensive medication and incident open-angle glaucoma. Ophthal mology. 2007;114:2221-2226.
20. Costagliola C, Parmeggiani F, Virgili G, et al. Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2008;246:389-396.
21. Drance SM, Crichton A, Mills RP. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. Am J Ophthalmol. 1998;125;585-592.
22. Fraunfelder ET. Ocular beta-blocker and systemic side effects. Arch Intern Med. 1986;146:1073-1074.
23. Hayreh SS, Podhajsky P, Zimmerman MB. Beta-blocker eyedrops and nocturnal arterial hypotension. Am J Ophthalmol. 1999;128: 301-309.
24. Korte JM, Kaila T, Saari KM. Systemic bioavailability and cardio-pulmonary effects of 0.5% timolol eyedrops. Graefes Arch Clin Exp Ophthalmol. 2002;240:430-435.
25. Unsitalo H, Turjanmaa Vm Bjarnhall G, Hedenstro MH, et al. Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients. Eur J Clin Pharmacol. 2005;61:369-374.
26. Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musing A, Gandolfo E. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Invest Ophthalmol Vis Sci. 2006;47:2917-2923.